HRMY
Harmony Biosciences Holdings Inc
Price:  
41.10 
USD
Volume:  
736,799.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRMY Relative Valuation

4.1%
Upside

As of 2026-09-11, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 42.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.10 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 4.1%.

The range of the Relative Valuation is 31.63 - 58.22 USD.

Range Selected
Trailing P/E multiples 10.1x - 13.5x 12.4x
Forward P/E multiples 11.8x - 17.3x 13.8x
Fair Price 31.63 - 58.22 42.77
Upside -23.1% - 41.7% 4.1%
41.10 USD
Stock Price
42.77 USD
Fair Price

HRMY Relative Valuation - Historical P/E Data

Date P/E
2026-09-09 13.29
2026-09-08 13.44
2026-09-04 13.49
2026-09-03 13.37
2026-09-02 13.69
2026-09-01 13.17
2026-08-31 12.58
2026-08-28 12.52
2026-08-27 12.73
2026-08-26 12.67
2026-08-25 12.44
2026-08-24 12.30
2026-08-21 12.18
2026-08-20 12.16
2026-08-19 12.75
2026-08-18 12.40
2026-08-17 12.18
2026-08-14 12.17
2026-08-13 12.30
2026-08-12 12.70
2026-08-11 12.62
2026-08-10 12.45
2026-08-07 12.27
2026-08-06 12.38
2026-08-05 12.21
2026-08-04 12.38
2026-08-03 11.37
2026-07-31 11.25
2026-07-30 11.45
2026-07-29 11.45
2026-07-28 11.42
2026-07-27 11.50
2026-07-24 11.28
2026-07-23 11.43
2026-07-22 11.13
2026-07-21 11.77
2026-07-20 10.70
2026-07-17 10.78
2026-07-16 10.71
2026-07-15 11.15
2026-07-14 11.12
2026-07-13 11.35
2026-07-10 11.77
2026-07-09 12.20
2026-07-08 12.16
2026-07-07 12.22
2026-07-06 11.82
2026-07-02 11.90
2026-07-01 11.50
2026-06-30 11.63